Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
India Pesticides Limited is a vertically integrated agrochemical manufacturer based in India, producing technical-grade pesticides, insecticides, herbicides, and fungicides for domestic and export markets. The company operates manufacturing facilities in Uttar Pradesh with backward integration into key intermediates, serving both B2B customers (formulation companies) and direct agricultural markets. Strong revenue growth (22% YoY) and improving margins reflect India's agricultural intensification and export opportunities, though negative FCF indicates ongoing capacity expansion.
IPL generates revenue by manufacturing active pharmaceutical ingredients (technical-grade pesticides) and formulations through backward-integrated facilities, capturing margin at multiple value chain stages. The company benefits from cost advantages through captive intermediate production, reducing dependence on imported raw materials. Pricing power derives from product registrations, technical expertise in complex chemistry, and relationships with multinational agrochemical companies. The 36% gross margin reflects manufacturing efficiency and product mix, while 12.2% operating margin indicates moderate fixed cost leverage from chemical plant operations.
Indian monsoon patterns and agricultural output - drives domestic pesticide demand and farmer purchasing power
Global agrochemical pricing trends and generic molecule opportunities as patents expire
Raw material cost inflation (crude derivatives, specialty chemicals from China) impacting gross margins
Capacity expansion execution and utilization rates at Uttar Pradesh facilities
Export order wins from multinational agrochemical companies and geographic diversification
Regulatory approvals for new molecule registrations in India and export markets
Regulatory risk from pesticide bans or restrictions in India and export markets as environmental standards tighten - several molecules face periodic review
Chinese competition in generic agrochemical manufacturing with lower cost structures and scale advantages
Shift toward biological pesticides and integrated pest management reducing synthetic chemical demand over 10+ year horizon
Climate volatility affecting agricultural patterns and pest pressure, creating demand unpredictability
Intense competition from larger Indian players (UPL, PI Industries) and multinational agrochemical companies with broader product portfolios and distribution networks
Customer concentration risk if dependent on few large B2B customers for technical-grade sales
Limited pricing power in commodity molecules where multiple manufacturers exist
Technology gap versus innovator companies in developing novel active ingredients
Negative free cash flow (-$0.6B) driven by aggressive capex program creates funding requirements despite low current debt
Working capital intensity in agrochemical business (seasonal inventory build, extended receivables) can strain liquidity during growth phases
Currency exposure on export revenues and imported raw material costs creates margin volatility
Environmental liability risk from chemical manufacturing operations and waste management
moderate - Agricultural demand shows resilience during economic downturns as food production remains essential, but farmer income and credit availability are GDP-linked. Indian rural consumption patterns, government support prices (MSP), and export demand from global agricultural markets create moderate cyclicality. Strong correlation with agricultural commodity prices and rural economic health rather than urban industrial activity.
Moderate sensitivity through two channels: (1) farmer credit availability and agricultural lending rates in India affect pesticide purchasing decisions, particularly for small/marginal farmers; (2) company's growth capex program (evidenced by $0.6B capex and negative FCF) creates financing cost exposure, though current 0.05x debt/equity suggests minimal leverage. Rising rates in India could pressure agricultural demand and increase cost of capacity expansion funding.
Moderate exposure to agricultural credit conditions in India. Pesticide purchases are often financed through seasonal crop loans, so tightening rural credit or higher agricultural lending rates reduce farmer purchasing power. Company's own credit needs are minimal given low leverage (0.05x D/E), but working capital financing for 60+ day receivables cycles creates some dependence on banking system liquidity.
growth - The 22% revenue growth, 36% earnings growth, and ongoing capacity expansion attract growth investors seeking exposure to India's agricultural modernization and import substitution themes. The 2.0x P/S and 11.2x EV/EBITDA multiples reflect growth premium versus mature chemical companies. Recent 20% six-month decline may attract value-oriented investors seeking entry points, but primary appeal is growth narrative.
high - Agricultural input stocks exhibit elevated volatility due to monsoon dependency, commodity price swings, and regulatory headline risk. The -20.4% six-month decline versus +23.9% one-year return demonstrates significant price swings. Small-cap positioning ($19B market cap in emerging market) and liquidity constraints amplify volatility versus large-cap chemical companies.
